These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 9816016

  • 1. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
    Bullock G, Ray S, Reed J, Miyashita T, Maria Ibrado A, Huang Y, Bhalla K.
    Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]

  • 3. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN.
    Cancer Res; 1998 Aug 01; 58(15):3202-8. PubMed ID: 9699642
    [Abstract] [Full Text] [Related]

  • 4. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K.
    Cell Growth Differ; 1996 Dec 01; 7(12):1617-23. PubMed ID: 8959329
    [Abstract] [Full Text] [Related]

  • 5. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
    Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC.
    Mol Pharmacol; 1994 Oct 01; 46(4):605-11. PubMed ID: 7969039
    [Abstract] [Full Text] [Related]

  • 6. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.
    Ponnathpur V, Ibrado AM, Reed JC, Ray S, Huang Y, Self S, Bullock G, Nawabi A, Bhalla K.
    Clin Cancer Res; 1995 Nov 01; 1(11):1399-406. PubMed ID: 9815937
    [Abstract] [Full Text] [Related]

  • 7. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD.
    Oncol Res; 1994 Nov 01; 6(2):87-99. PubMed ID: 7949469
    [Abstract] [Full Text] [Related]

  • 8. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.
    Cell Growth Differ; 1996 May 01; 7(5):603-13. PubMed ID: 8732670
    [Abstract] [Full Text] [Related]

  • 9. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA, Helmbach H, Artuc M, Karmann D, Jurgovsky K, Schadendorf D.
    Anticancer Res; 1997 May 01; 17(6D):4359-70. PubMed ID: 9494534
    [Abstract] [Full Text] [Related]

  • 10. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA.
    Cancer Res; 1992 Nov 15; 52(22):6270-8. PubMed ID: 1423273
    [Abstract] [Full Text] [Related]

  • 11. Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells.
    Kharbanda S, Rubin E, Gunji H, Hinz H, Giovanella B, Pantazis P, Kufe D.
    Cancer Res; 1991 Dec 15; 51(24):6636-42. PubMed ID: 1742737
    [Abstract] [Full Text] [Related]

  • 12. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
    Bullock G, Ray S, Reed JC, Krajewski S, Ibrado AM, Huang Y, Bhalla K.
    Leukemia; 1996 Nov 15; 10(11):1731-40. PubMed ID: 8892676
    [Abstract] [Full Text] [Related]

  • 13. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells.
    Tang C, Willingham MC, Reed JC, Miyashita T, Ray S, Ponnathpur V, Huang Y, Mahoney ME, Bullock G, Bhalla K.
    Leukemia; 1994 Nov 15; 8(11):1960-9. PubMed ID: 7526093
    [Abstract] [Full Text] [Related]

  • 14. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B, Dubrez L, Allouche M, Solary E.
    Cancer Res; 1997 Feb 15; 57(4):686-95. PubMed ID: 9044846
    [Abstract] [Full Text] [Related]

  • 15. [Studies on programmed cell death induced by amsacrine and expression of bcl-2 in leukemia cell lines].
    Wan Y, Wu D.
    Zhonghua Zhong Liu Za Zhi; 1997 Sep 15; 19(5):346-9. PubMed ID: 10920913
    [Abstract] [Full Text] [Related]

  • 16. Effect of Bcl-2 on ionizing radiation and 1-beta-D-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells.
    Manome Y, Weichselbaum RR, Kufe DW, Fine HA.
    Oncol Res; 1993 Sep 15; 5(3):139-44. PubMed ID: 8260751
    [Abstract] [Full Text] [Related]

  • 17. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
    Yang JS, Hour MJ, Kuo SC, Huang LJ, Lee MR.
    Anticancer Res; 2004 Sep 15; 24(3a):1769-78. PubMed ID: 15274354
    [Abstract] [Full Text] [Related]

  • 18. [The mechanism of apoptosis induced by anticancer agents in human leukemia HL-60 cells].
    Yoshida A, Ueda T, Nakamura T.
    Rinsho Ketsueki; 1996 Jul 15; 37(7):552-7. PubMed ID: 8779771
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents.
    Kobayashi T, Ruan S, Clodi K, Kliche KO, Shiku H, Andreeff M, Zhang W.
    Oncogene; 1998 Mar 26; 16(12):1587-91. PubMed ID: 9569026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.